Search results for " hepatoblastoma"

showing 3 items of 3 documents

NEOPLASIE EPITELIALI MALIGNE DEL FEGATO IN ETA' PEDIATRICA: Analisi dello Studio Cooperativo Nazionale HEPA 88

1992

The Authors analyze the preliminary results of the first Italian Cooperative Research program on childhood malignant epithelial liver tumors. The value of radical surgery and the effectiveness of cisplatin and adriamycin in inducing tumor response are undelined.

Settore MED/38 - Pediatria Generale E SpecialisticaSettore MED/20 - Chirurgia Pediatrica E Infantileliver tumors hepatoblastoma heparocellular carcinoma
researchProduct

Molecular bases of the poor response of liver cancer to chemotherapy

2018

Summary A characteristic shared by most frequent types of primary liver cancer, i.e., hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) in adults, and in a lesser extent hepatoblastoma (HB) mainly in children, is their high refractoriness to chemotherapy. This is the result of synergic interactions among complex and diverse mechanisms of chemoresistance (MOC) in which more than 100 genes are involved. Pharmacological treatment, although it can be initially effective, frequently stimulates the expression of MOC genes, which results in the relapse of the tumor, usually with a more aggressive and less chemosensitive phenotype. Identification of the MOC genetic signature accounting fo…

0301 basic medicineHepatoblastomaCarcinoma HepatocellularGenetic enhancementmedicine.medical_treatmentCholangiocarcinoma03 medical and health sciences0302 clinical medicineHumansMedicinecholangiocarcinoma; hepatoblastoma; hepatocellular carcinoma; multidrug resistance; targeted therapies; hepatology; gastroenterologyChemotherapyHepatologybusiness.industryLiver NeoplasmsGastroenterologymedicine.diseasePhenotypeResistome030104 developmental biologyDrug Resistance Neoplasm030220 oncology & carcinogenesisHepatocellular carcinomaCancer cellCancer researchbusinessLiver cancerClinics and Research in Hepatology and Gastroenterology
researchProduct

Inhibition of Cancer Derived Cell Lines Proliferation by Synthesized Hydroxylated Stilbenes and New Ferrocenyl-Stilbene Analogs. Comparison with Resv…

2014

Further advances in understanding the mechanism of action of resveratrol and its application require new analogs to identify the structural determinants for the cell proliferation inhibition potency. Therefore, we synthesized new trans-resveratrol derivatives by using the Wittig and Heck methods, thus modifying the hydroxylation and methoxylation patterns of the parent molecule. Moreover, we also synthesized new ferrocenylstilbene analogs by using an original protective group in the Wittig procedure. By performing cell proliferation assays we observed that the resveratrol derivatives show inhibition on the human colorectal tumor SW480 cell line. On the other hand, cell viability/cytotoxicit…

StereochemistryCell SurvivalPharmaceutical ScienceResveratrolresveratrolArticleAnalytical Chemistrylcsh:QD241-441chemistry.chemical_compoundlcsh:Organic chemistryIntestinal mucosaCell Line TumorDrug DiscoveryStilbenesresveratrol; methoxystilbenes; ferrocenylstilbene analogs; colon cancer; hepatoblastomaHumansViability assayFerrous CompoundsPhysical and Theoretical ChemistrymethoxystilbenesIntestinal MucosaCytotoxicityCell ProliferationCell growthferrocenylstilbene analogsOrganic ChemistryCell CycleEpithelial CellsHep G2 CellsCell cyclehepatoblastomaBiochemistrychemistrycolon cancerChemistry (miscellaneous)Cell cultureCancer cellMolecular MedicineColorectal NeoplasmsMolecules
researchProduct